Obstructive sleep apnoea: Clinical signs, diagnosis and treatment

Nephrology Dialysis Transplantation

Volumn 24, Issue 1, 2009, Pages 8-14

  Kuhlmann, Uwe ^a   Bormann, Felix Georg ^a   Becker, Heinrich Friedrich ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ASKLEPIOS HOSPITAL BARMBEK   (Germany)

Author keywords

Chronic kidney disease; Sleep; Sleep apnoea; Sleep disorders

Indexed keywords

AIRWAY PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAM; HUMAN; HYPOVENTILATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REM SLEEP; RHINITIS; SLEEP APNEA SYNDROME; SLEEP DISORDER;

CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 58049202247     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn510     Document Type: Article

References (76)

1. Drazen JM. Sleep apnoea syndrome. N Engl J Med 2002; 346: 390
2. Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746-1752
3. Peppard PE, Young T, Palta M et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384
4. Bixler EO, Vgontzas AN, Lin HM et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000; 160: 2289-2295
5. Duran J, Esnaola S, Rubio R et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163(Pt 1): 685-689
6. Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA 2000; 283: 1829-1836
7. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-482
8. Grote L, Ploch T, Heitmann J et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999; 160: 1875-1882
9. Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572
10. Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001; 163: 19-25
11. Arzt M, Young T, Finn L et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447-1451
12. Becker H, Brandenburg U, Peter JH et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151: 215-218
13. Grimm W, Hoffmann J, Menz V et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996; 77: 1310-1314
14. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008; 177(4): 369-75
15. Suzuki YJ, Jain V, Park AM et al. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006; 40: 1683-1692
16. Schulz R, Schmidt D, Blum A et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55: 1046-1051
17. Ip MS, Lam B, Chan LY et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162: 2166-2171
18. Lattimore JD, Wilcox I, Adams MR et al. Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release. Int J Cardiol 2008; 126(2): 229-233
19. Lattimore JL, Wilcox I, Skilton M et al. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006; 61: 491-495
20. Kato M, Roberts-Thomson P, Phillips BG et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610
21. Haight JS, Djupesland PG. Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath 2003; 7: 53-62
22. Foster GE, Poulin MJ, Hanly PJ. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 2007; 92: 51-65
23. Schulz R, Mahmoudi S, Hattar K et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162(Pt 1): 566-570
24. Büchner N, Vonend O, Rump LC. Pathophysiologie der Hypertonie: was gibt es Neues? [Pathophysiology of hypertension: what's new?] Herz 2006; 31: 294-302
25. Brown DL. Sleep disorders and stroke. Semin Neurol 2006; 26: 117-122
26. Minoguchi K, Yokoe T, Tazaki T et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 175: 612-617
27. Fletcher EC. Obstructive sleep apnoea and the kidney. J Am Soc Nephrol 1993; 4: 1111-1121
28. Zhang L, Huang X, Li X et al. Alterations in renal function in patients with obstructive sleep apnoea syndrome and effects of continuous positive airway pressure. Chin Med J (Engl) 1997; 110: 915-918
29. Calhoun DA, Nishizaka MK, Zaman MA et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnoea. Chest 2004; 125: 112-117
30. Kinebuchi S, Kazama JJ, Satoh M et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 2004; 107: 317-322
31. Wissing KR, Büchner NJ, Stegbauer J et al. Renaler widerstandsindex bei obstruktiver Schlafapnoe [Renal resistance index in patients with obstructive sleep apnea]. Dtsch Med Wochenschr 2007; 132: 1815-1819
32. Büchner NJ, Henning BF, Hägele KF et al. Nierenfunktion bei hypertensiven Patienten mit obstruktiver Schlafapnoe [Renal function in hypertensive patients with obstructive sleep apnea]. Dtsch Med Wochenschr 2004; 129: 305-309
33. Sahebjani H. Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. Chest 1998; 113: 1604-1608
34. Iliescu EA, Lam M, Pater J et al. Do patients with obstructive sleep apnoea have clinically significant proteinuria? Clin Nephrol 2001; 55: 196-204
35. Casserly LF, Chow N, Ali S et al. Proteinuria in obstructive sleep apnoea. Kidney Int 2001; 60: 1484-1489
36. Mello P, Franger M, Boujaoude Z et al. Night and day proteinuria in patients with sleep apnoea. Am J Kidney Dis 2004; 44: 636-641
37. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509
38. Praga M, Hernandez E, Morales E et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001; 16: 1790-1798
39. Faulx MD, Storfer-Isser A, Kirchner HL et al. Obstructive sleep apnea is associated with increased urinary albumin excretion. SLEEP 2007; 30: 923-929
40. Kuhlmann U, Becker HF, Birkhahn M et al. Sleep-apnoea in patients with end-stage renal disease and objective results. Clin Nephrol 2000; 53: 460-466
41. Jurado-Gamez B, Martin-Malo A, Alvarez-Lara MA et al. Sleep disorders are underdiagnosed in patients on maintenance hemodialysis. Nephron Clin Pract 2007; 105: c35-c42
42. Tada T, Kusano KF, Ogawa A et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant 2007; 22: 1190-1197
43. Zoccali C, Mallamaci F, Tripepi G. Sleep apnea in renal patients. J Am Soc Nephrol 2001; 12: 2854-2859
44. Benz RL, Pressman MR, Hovick ET et al. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis 2000; 35: 1052-1060
45. Vgontzas AN, Papanicolaou DA, Bixler EO et al. Sleep apnoea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-1158
46. Tang SC, Lam B, Ku PP et al. Alleviation of sleep apnoea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2607-2616
47. Erten Y, Kokturk O, Yuksel A et al. Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients. Nephrology(Carlton) 2005; 10: 330-335
48. Beecroft J, Duffin J, Pierratos A et al. Enhanced chemoresponsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J 2006; 28: 151-158
49. Beecroft JM, Hoffstein V, Pierratos A et al. Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 2008; 23(2): 673-679
50. Bucca CB, Brussino L, Battisti A et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007; 132: 440-446
51. Mendelson WB, Wadhwa NK, Greenberg HE et al. Effects of hemodialysis on sleep apnoea syndrome in end-stage renal disease. Clin Nephrol 1990; 33: 247-251
52. Hanly PJ, Pierratos A. Improvement of sleep apnoea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344: 102-107
53. Miskowiec I, Klawe JJ, Tafil-Klawe M et al. Prevalence of sleep apnea syndrome in hemodialyzed patients with end-stage renal disease. J Physiol Pharmacol 2006; 57(Suppl 4): 207-211
54. Unruh ML, Sanders MH, Redline S et al. Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study. J Am Soc Nephrol 2006; 17: 3503-3509
55. Argekar P, Griffin V, Litaker D et al. Sleep apnea in hemodialysis patients: risk factors and effect on survival. Hemodial Int 2007; 11: 435-441
56. Novak M, Mendelssohn D, Shapiro CM et al. Diagnosis and management of sleep apnoea syndrome and restless legs syndrome in dialysis patients. Semin Dial 2006; 19: 210-216
57. Beecroft JM, Zaltzman J, Prasad R et al. Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 2007; 22: 3028-3033
58. Molnar MZ, Szentkiralyi A, Lindner A et al. High prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation - association with declining renal function. Nephrol Dial Transplant 2007; 22: 2686-2692
59. Jung HH, Han H, Lee JH. Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis 2005; 45: 875-882
60. Zoccali C, Benedetto FA, Mallamaci F et al. Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients. J Hypertens 2001; 19: 287-293
61. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol 2002; 13: 729-733
62. de Oliveira Rodrigues CJ, Marson O, Tufic S et al. Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients. Am J Hypertens 2005; 18(Pt 1): 152-157
63. Pang KP, Terris DJ. Screening for obstructive sleep apnea: an evidence-based analysis. Am J Otolaryngol 2006; 27: 112-118
64. Fischer J, Mayer G, Peter JH et al. Nicht-erholsamer schlaf. Leitlinie "S2" der deutschen gesellschaft für schlafforschung und schlafmedizin (DGSM). Somnologie 2001; 5(Suppl 3): 41-59
65. Penzel T, Hajak G, Hoffmann RM et al. Empfehlungen zur durchführung und auswertung polygraphischer ableitungen im diagnostischen schlaflabor. Z Eeg Emg 1993; 24: 65-70
66. Peppard PE, Young T, Palta M et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015-3021
67. Taasan VC, Block AJ, Boysen PG et al. Alcohol increases sleep apnoea and oxygen desaturation in asymptomatic men. Am J Med 1981; 71: 240-245
68. Noda A, Nakai S, Soga T et al. Factors contributing to sleep disturbance and hypnotic drug use in hemodialysis patients. Intern Med 2006; 45: 1273-1278
69. Fietze I, Bölcskei PL, Hörmann K et al. Komplikationen bei der nasalen CPAP-therapie: konsequenzen für die praxis. Med Klin 1996; 91: 758-765
70. Krieger J, Weitzenblum E, Monassier JP et al. Dangerous hypoxaemia during continuous positive airway pressure treatment of obstructive sleep apnoea. Lancet 1983; 2: 1429-1430
71. Alajmi M, Mulgrew AT, Fox J et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: ameta-analysis of randomized controlled trials. Lung 2007; 185: 67-72
72. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnoea. Circulation 2003; 107: 68-73
73. Basner RC. Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med 2007; 356: 1751-1758
74. Campos-Rodriguez F, Peña-Griñan N, Reyes-Nuñez N et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005; 128: 624-633
75. Marti S, Sampol G, Muñoz X et al. Mortality in severe sleep apnoea/ hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20: 1511-1518
76. Marin JM, Carrizo SJ, Vicente E et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053